Abstract
Aim:
To investigate the effect of genistein on bone homeostasis in mandibular subchondral bone of rats.
Methods:
Female SD rats were administered with genistein (10 and 50 mg/kg) or placebo by oral gavage for 6 weeks. Then the animals were sacrificed, and histomorphology and micro-structure of mandibular condyle were examined using HE staining and micro-CT analysis, respectively. The expression levels of alkaline phosphatase (ALP), osteocalcin (OC), osteoprotegerin (OPG), the receptor activator of nuclear factor κB ligand (RANKL) and estrogen receptors (ERs) in mandibular condyle were detected using real-time PCR. Cultured osteoblasts were prepared from rat mandibular condyle for in in vitro study. The cells were treated with genistein (10−7 or 10−4 mol/L) for 48 h. The expression of the bone homeostasis-associated factors and estrogen receptors (ERs) was detected using real-time PCR, and ER silencing was performed.
Results:
At both the low- and high-doses, genistein significantly increased the bone mineral density (BMD) and bone volume, and resulted in thicker subchondral trabecular bone in vivo. In both in vivo and in vitro study, the low-dose genistein significantly increased the expression of ALP, OC and OPG, but decreased the expression of RANKL and the RANKL/OPG ratio. The high-dose genistein decreased the expression of all these bone homeostasis-associated factors. Both the low and high doses of genistein significantly increased the expression of ERβ, while ERα expression was increased by the low dose genistein and decreased by the high dose genistein. ERβ silencing abrogated most of the effects of genistein treatment.
Conclusion:
In rat mandibular condylar subchondral bone, low-dose genistein increases bone formation and inhibit bone resorption, while excess genistein inhibits both bone formation and resorption. The effects of genistein were predominantly mediated through ERβ.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Hohenhaus MH, McGarry KA, Col NF . Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option? Drugs 2007; 67: 2311–21.
Levine JP . Effective strategies to identify postmenopausal women at risk for osteoporosis. Geriatrics 2007; 62: 22–30.
Fitzpatrick LA . Estrogen therapy for postmenopausal osteoporosis. Arq Bras Endocrinol Metabol 2006; 50: 705–19.
Nevitt MC, Cummings SR, Lane NE, Hochberg MC, Scott JC, Pressman AR, et al. Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1996; 156: 2073–80.
Zhang Y, McAlindon TE, Hannan MT, Chaisson CE, Klein R, Wilson PW, et al. Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study. Arthritis Rheum 1998; 41: 1867–73.
Spector TD, Nandra D, Hart DJ, Doyle DV . Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford Study. Ann Rheum Dis 1997; 56: 432–4.
Stevenson JC . Hormone replacement therapy: review, update, and remaining questions after the Women's Health Initiative Study. Curr Osteoporos Rep 2004; 2: 12–6.
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997; 350: 1047–59.
Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–27.
Setchell KD, Lydeking-Olsen E . Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 2003; 78: 593S–609S.
Messina M, Ho S, Alekel DL . Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data. Curr Opin Clin Nutr Metab Care 2004; 7: 649–58.
Chanawirat A, Khemapech S, Patumraj S, Siriviriyakul P . Genistein replacement therapy on endothelial dysfunction and bone loss in bilateral ovariectomized rats. Clin Hemorheol Microcirc 2006; 34: 309–14.
Erlandsson MC, Islander U, Moverare S, Ohlsson C, Carlsten H . Estrogenic agonism and antagonism of the soy isoflavone genistein in uterus, bone and lymphopoiesis in mice. APMIS 2005; 113: 317–23.
Chen YM, Ho SC, Lam SS, Ho SS, Woo JL . Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial. Menopause 2004; 11: 246–54.
Wu J, Oka J, Higuchi M, Tabata I, Toda T, Fujioka M, et al. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metabolism 2006; 55: 423–33.
Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 2002; 17: 1904–12.
Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 2007; 146: 839–47.
Li B, Yu S . Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol Pharm Bull 2003; 26: 780–6.
Sliwiński L, Folwarczna J, Nowińska B, Cegieła U, Pytlik M, Kaczmarczyk-Sedlak I, et al. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system. Acta Biochim Pol 2009; 56: 261–70.
Bitto A, Burnett BP, Polito F, Marini H, Levy RM, Armbruster MA, et al. Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. Br J Pharmacol 2008; 155: 896–905.
Tähtelä R, Thölix E . Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer. Anticancer Res 1996; 16: 2289–93.
Shoji K, Elsubeihi ES, Heersche JN . Effects of ovariectomy on turnover of alveolar bone in the healed extraction socket in rat edentulous mandible. Arch Oral Biol 2011; 56: 114–20.
Jonasson G, Alstad T, Vahedi F, Bosaeus I, Lissner L, Hakeberg M . Trabecular pattern in the mandible as bone fracture predictor. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: e42–51.
Griffin CJ, Powers R, Kruszynski R . The incidence of osteoarthritis of the temporomandibular joint in various cultures. Aust Dent J 1979; 24: 94–106.
Milam SB . Pathophysiology and epidemiology of TMJ. J Musculoskelet Neuronal Interact 2003; 3: 382–90.
Jiao K, Dai J, Wang MQ, Niu LN, Yu SB, Liu XD . Age- and sex-related changes of mandibular condylar cartilage and subchondral bone: a histomorphometric and micro-CT study in rats. Arch Oral Biol 2010; 55: 155–63.
Michael MR, Wolz E, Davidovich A, Pfannkuch F, Edwards JA, Bausch J . Acute, subchronic and chronic safety studies with genistein in rats. Food Chem Toxicol 2006; 44: 56–80.
Seibel J, Molzberger AF, Hertrampf T, Laudenbach-Leschowski U, Diel P . Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur J Nutr 2009; 48: 213–20.
Viereck V, Gründker C, Blaschke S, Siggelkow H, Emons G, Hofbauer LC . Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J Cell Biochem 2002; 84: 725–35.
Ishida H, Uesugi T, Hirai K, Toda T, Nukaya H, Yokotsuka K, et al. Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 1998; 21: 62–6.
Nakajima D, Kim CS, Oh TW, Yang CY, Naka T, Igawa S, et al. Suppressive effects of genistein dosage and resistance exercise on bone loss in ovariectomized rats. J Physiol Anthropol Appl Human Sci 2001; 20: 285–91.
Ye SF, Saga I, Ichimura K, Nagai T, Shinoda M, Matsuzaki S . Coumestrol as well as isoflavones in soybean extract prevent bone resorption in ovariectomized rats. Endocr Regul 2003; 37: 145–52.
Pie JE, Park JH, Park YH, Ryu YM, Kim KN, Suh SW, et al. Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray. J Nutr Biochem 2006; 17: 157–64.
Hertrampf T, Gruca MJ, Seibel J, Laudenbach U, Fritzemeier KH, Diel P . The bone-protective effect of the phytoestrogen Genistein is mediated via ERα-dependent mechanisms and strongly enhanced by physical activity. Bone 2007; 40: 1529–35.
Hertrampf T, Schleipen B, Offermanns C, Velders M, Laudenbach U, Diel P . Comparison of the bone protective effects of an isoflavone-rich diet with dietary and subcutaneous administrations of genistein in ovariectomized rats. Toxicol Lett 2009; 184: 198–203.
Dai R, Ma Y, Sheng Z, Jin Y, Zhang Y, Fang L, et al. Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats. J Bone Miner Metab 2008; 26: 342–9.
Cheng P, Ma X, Xue Y, Li S, Zhang Z . Effects of estradiol on proliferation and metabolism of rabbit mandibular condylar cartilage cells in vitro. Chin Med J (Engl) 2003; 116: 1413–7.
Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D, Ando S . Estrogen receptor α mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol 2001; 60: 595–602.
Power KA, Thompson LU . Ligand-induced regulation of ERα and ERβ is indicative of human breast cancer cell proliferation. Breast Cancer Res Treat 2003; 82: 209–21.
Rajah TT, Du N, Drews N, Cohn R . Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells. Pharmacology 2009; 84: 68–73.
Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, et al. OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. J Bone Miner Res 2008; 23: 715–20.
Crisafulli A, Altavilla D, Squadrito G, Romeo A, Adamo EB, Marini R, et al. Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women. J Clin Endocrinol Metab 2004; 89: 188–92.
Zhang Y, Li Q, Wan HY, Helferich WG, Wong MS . Genistein and a soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice. J Nutr 2009; 139: 2230–6.
Ha H, Lee HY, Lee JH, Jung D, Choi J, Song KY, et al. Formononetin prevents ovariectomy-induced bone loss in rats. Arch Pharm Res 2010; 33: 625–32.
Lerner UH . Bone remodeling in post-menopausal osteoporosis. J Dent Res 2006; 85: 584–95.
Velders M, Solzbacher M, Schleipen B, Laudenbach U, Fritzemeier KH, Diel P . Estradiol and genistein antagonize the ovariectomy effects on skeletal muscle myosin heavy chain expression via ER-beta mediated pathways. J Steroid Biochem Mol Biol 2010; 120:53–9.
Lee K, Jessop H, Suswillo R, Zaman G, Lanyon L . Endocrinology: bone adaptation requires oestrogen receptor-alpha. Nature 2003; 424: 389.
Lee KC, Jessop H, Suswillo R, Zaman G, Lanyon LE . The adaptive response of bone to mechanical loading in female transgenic mice is deficient in the absence of oestrogen receptor-alpha and -beta. J Endocrinol 2004; 182: 193–201.
Jessop HL, Suswillo RF, Rawlinson SC, Zaman G, Lee K, Das-Gupta V, et al. Osteoblast-like cells from estrogen receptor alpha knockout mice have deficient responses to mechanical strain. J Bone Miner Res 2004; 19: 938–46.
Zaman G, Cheng MZ, Jessop HL, White R, Lanyon LE . Mechanical strain activates estrogen response elements in bone cells. Bone 2000; 27: 233–9.
Acknowledgements
The authors thank Mr Jun WANG (Xijing Hospital, Fourth Military Medical University) for technical assistance in Micro-CT. This work was financially supported by the National Natural Science Foundation of China (No 30901699 and No 30928028).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Li, Yq., Xing, Xh., Wang, H. et al. Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone. Acta Pharmacol Sin 33, 66–74 (2012). https://doi.org/10.1038/aps.2011.136
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2011.136
Keywords
This article is cited by
-
Molecular signaling mechanisms behind polyphenol-induced bone anabolism
Phytochemistry Reviews (2017)
-
Selective ligands of estrogen receptor β discovered using pharmacophore mapping and structure-based virtual screening
Acta Pharmacologica Sinica (2014)
-
Excess genistein suppresses the synthesis of extracellular matrix in female rat mandibular condylar cartilage
Acta Pharmacologica Sinica (2012)
